Correction to: Isoprenylated Flavonoids as Ca v 3.1 Low Voltage-Gated Ca 2+ Channel Inhibitors from Salvia digitaloides
2021-04-03JianJunZhaoSongYuLiFanXiaYaLiHuYinNianGangXu
Jian-Jun Zhao ·Song-Yu Li ·Fan Xia·Ya-Li Hu ·Yin Nian ·Gang Xu
Correction to: Natural Products and Bioprospecting
https:// doi.org/ 10.1007/ s13659- 021- 00307-y
In the original publication, the authors contributing equally to this paper was not presented clear.
The corrected text is given below:
Jian-Jun Zhao and Song-Yu Li have contributed equally to this work.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.To view a copy of this license, visit http:// creat iveco mmons.org/ licen ses/ by/4.0/.
杂志排行
Natural Products and Bioprospecting的其它文章
- Isoprenylated Flavonoids as Ca v3.1 Low Voltage-Gated Ca2+ Channel Inhibitors from Salvia digitaloides
- Scutellarin Reduces Cerebral Ischemia Reperfusion Injury Involving in Vascular Endothelium Protection and PKG Signal
- Furostanol Saponins from Asparagus cochinchinensis and Their Cytotoxicity
- Six New 3,5-Dimethylcoumarins from Chelonopsis praecox,Chelonopsis odontochila and Chelonopsis pseudobracteata
- Anticancer Properties and Mechanism of Action of Oblongifolin C, Guttiferone K and Related Polyprenylated Acylphloroglucinols
- Natural Products as Potential Lead Compounds for Drug Discovery Against SARS-CoV-2